Company Focus

The NHS has committed to increasing capacity to deliver more procedures and scans over the next three years, to around nine million more tests and checks by 2025.This will mean that over a three-year period, patients will be offered around 17 million more diagnostic tests – an increase in capacity of a quarter compared with the three years prior to the pandemic.
New surgical hubs will also be added to the network of 122 already operating across the country, helping ensure that unless people chose to postpone, the longest time patients could wait will reduce so that by March 2025 patients aren’t waiting longer than a year for surgery. The hubs focus on high-volume routine surgery so more patients can get seen more quickly, making efficient use of taxpayer resources, and creating extra capacity so emergency cases do not disrupt operations and cause cancellations or delays.
The NHS ‘new elective care recovery plan’ that supports the above, developed with Royal Colleges, patient groups and health charities, sets out how the NHS staff will make the best use of additional government funding to begin to address the surgical COVID backlog.
Our innovation fits with the strategy, which is being designed similarly in every market around the world. The business model for us will be slightly different but our innovations deliverables are significantly similar for all markets. In that we can help providers address patient needs, improve the quality and capacity of pre-assessment services, help bring down waiting lists. Fast track patients to successful surgery, reduce their risk of complications and plan better after care. Integrate with healthcare provider systems and future proofing surgical preassessment and procedure systems by providing a virtual remotely managed service that is not dependant on face to face assessment; the downfall of the for providers during the pandemic.

Current surgical pre and post operative assessment models have limitations
Standardising pre and post operative assessment with a remote care assessment model will address current model limitations

The gap in the market we are addressing is muti fold:
1. Currently, surgical pre assessment is centered on face-to-face consultation by the patient at a fixed location; a hospital pre assessment clinic.
2. Limited set of clinical data to calculate patients ‘fitness for surgery index’ during the above.
3. Clinics are reliant on location fixed standard exercise testing tools ‘cardiopulmonary exercise testing (CPET) which are unable to transition to virtual remotely managed services.
4. Providers are struggling to increase pre assessment service capacity and likely to miss referral and address surgical backlogs targets.

NHS providers, and others internationally, are seeking remote digital device and software innovations to address the above challenge and system gaps.

The Asclepius System is unique:
1. Records more data and builds a valuable patient longitudinal multimodal dataset and with clever AI predicative algorithms calculates a more accurate ‘fitness for surgery index’.
2. Is not fixed to locations and patients are issued with a wearable biosensor and record self-reported data in the app, to use at home, or work or other for 7 days.
3. Reduces unnecessary clinic visits with no requirement for the patient to return for follow up consults.
4. Healthcare professionals can in real time remotely access patient data in the patient’s dashboard. Analyse and automate reporting data, with intelligent AI, to inform shared decision making with the surgical, anaesthetist and surgical planning teams.
5. Speeds up time to surgical procedure.
6. The Asclepisu System is co-designed with patients for high user-acceptability.
7. Is less expensive that CPET testing.